Parabolic Drugs
Dr. Akshay Tiwari has extensive experience in the pharmaceutical industry, currently serving as SRA at Parabolic Drugs since August 2010. Prior to this role, Dr. Tiwari was an Officer in Research and Development at Ipca Laboratories Ltd from November 2006 to August 2010. Dr. Tiwari obtained a Doctorate in Philosophy with a specialization in Organic Chemistry from the School of Studies in Chemistry, completing the degree between 2002 and 2004.
This person is not in any offices
Parabolic Drugs
Parabolic Drugs Limited is a vertically integrated, research based, Pharmaceutical manufacturer and exporter, specializing in development and manufacturing of Active Pharmaceutical Ingredients (API) and API intermediates. The Company has dedicated facilities for Custom Research and API manufacturing at its 4 locations, 2 in Haryana (India) and 2 in Punjab (India) and exporting to over 51 countries across the globe from its WHO-GMP facilities. Parabolic has a wide Product basket, ranging from Oral and Sterile Semi Synthetic Penicillin API, Oral and Sterile Cephalosporin API in antibiotic segment to non-antibiotic API in the Cardiovascular, NSAID, Anti-Hypertensive and Osteoporosis segments. The Company has a clear vision to be a fully integrated Pharmaceutical Company providing world class pharmaceutical products and services, from development of API intermediates to API contract manufacture to supplying finished formulations, for both generic and Innovator companies across the globe. The Company has a very strong IPR and Regulatory Wing for all kinds of DMF and dossier support and is committed to highest standards of quality in all its operations. Its core strength lies in its edge in complex chemistry reactions with rich experience in organic chemistry, consistent quality in output, timely deliveries and strong documentation support.